3 completed, 2 terminated, 1 recruiting, 1 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 3, Terminated 2, Recruiting 1, Unknown 1 |
Follow MDS: new trials by email Literature Review of MDS trials Research Report on MDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quality of Life-Guided Transfusion in Refractory MDS or AML Red blood cell transfusions based on EQ-5D-5L questionnaire - MDS, AML, Adult | Not applicable | Recruiting | Centre Hospitalier Universitaire de Nice | 52 | 2026-02-09 | 2026-02-12 |
| Mutational Analysis as a Prognostic and Predictive Marker of Cardiovascular (CVD) Disease in Patients With Myelodysplasia Genetic Mutations, Inflammatory and lipid markers, Computed Tomography (CT) of the heart - MDS, Cardiovascular Diseases | Not applicable | Unknown | Sunnybrook Health Sciences Centre | 400 | 2019-09-01 | 2019-10-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk transplantation - MDS | Not applicable | Completed | Groupe Francophone des Myelodysplasies | 79 | 2016-05-31 | 2024-08-02 |
| FLT-PET Imaging for MDS FLT-PET scans - AML, MDS | Not applicable | Terminated | University of Wisconsin, Madison | 1 | 2012-07-01 | 2019-12-13 |
| Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) Romiplostim (formerly AMG 531) - Hematology, MDS | Not applicable | Completed | Amgen | 72 | 2007-04-01 | 2017-12-29 |
| Stem Cell Transplant for Hematological Malignancy Stem Cell Transplant, Cyclophosphamide, Total Body Irradiation - Leukemia, Myeloid, Chronic, AML | Not applicable | Terminated | Masonic Cancer Center, University of Minnesota | 330 | 2001-10-01 | 2021-01-22 |
| Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia Donor Lymphocyte Infusion - Leukemia, Myeloid, Chronic, AML | Not applicable | Completed | Masonic Cancer Center, University of Minnesota | 40 | 1995-12-01 | 2017-11-29 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia (1) · Cardiovascular Diseases (1) · Hodgkin Disease (1) · Inflammation (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Recurrence (1) · Thrombocytopenia (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Bone Marrow Diseases (4) · Leukemia (3) · Leukemia, Myeloid (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Disease Attributes (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2)
Antilymphocyte Serum (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Cyclophosphamide (1) · Mutation (1) · Radiotherapy (1) · Stem Cell Transplantation (1) · Transplantation (1) · Whole-Body Irradiation (1) · romiplostim (1)
Masonic Cancer Center, University of Minnesota (2) · Amgen (1) · Centre Hospitalier Universitaire de Nice (1) · Groupe Francophone des Myelodysplasies (1) · Sunnybrook Health Sciences Centre (1) · University of Wisconsin, Madison (1)
United States (3) · France (2) · Canada (1)
Daniel Weisdorf, MD (1) · Jeffrey Miller, MD (1) · Marie Robin, MD (1) · Rashmi S Goswani, MD (1) · Ryan J Mattison, MD (1) · Thomas Cluzeau (1)